Nuveen’s Nautilus Biotechnolgy NAUT Stock Holding History

Nuveen’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124K	Buy	+66,202	New	+$175K	﹤0.01%	3699
2025 Q2	–	Sell	-193,591	Closed	-$167K	–	3353
2025 Q1	$167K	Hold	193,591	–	–	﹤0.01%	3154
2024 Q4	$325K	Hold	193,591	–	–	﹤0.01%	3110
2024 Q3	$552K	Hold	193,591	–	–	﹤0.01%	2982
2024 Q2	$453K	Hold	193,591	–	–	﹤0.01%	3029
2024 Q1	$569K	Hold	193,591	–	–	﹤0.01%	2932
2023 Q4	$579K	Buy	193,591 +3,279	+2%	+$9.38K	﹤0.01%	2956
2023 Q3	$601K	Sell	190,312 -1,609	-0.8%	-$5.24K	﹤0.01%	2782
2023 Q2	$743K	Buy	191,921 +24,809	+15%	+$71.5K	﹤0.01%	2785
2023 Q1	$463K	Sell	167,112 -17,668	-10%	-$37.1K	﹤0.01%	2825
2022 Q4	$333K	Sell	184,780 -24,486	-12%	-$47.3K	﹤0.01%	2964
2022 Q3	$443K	Buy	209,266 +3,499	+2%	+$8.8K	﹤0.01%	2984
2022 Q2	$553K	Buy	+205,767	New	+$766K	﹤0.01%	2987

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Nuveen's NAUT Position: Q2 2026 in Review

Nuveen opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 66,202 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #3699 among its holdings. This is a return to the name: Nuveen previously reported a position in NAUT as recently as Q1 2025.

Nuveen first reported a position in NAUT in Q2 2022 and has held it in 13 quarters since. The position peaked at $743K in Q2 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Nuveen held 66,202 shares of Nautilus Biotechnolgy worth $124K as of Q2 2026.
Nautilus Biotechnolgy was a new Nuveen position in Q2 2026.
Nautilus Biotechnolgy made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3699 holding.
Nuveen first reported a position in Nautilus Biotechnolgy in Q2 2022 and has held it in 13 quarters since.
Nuveen's Nautilus Biotechnolgy position peaked at $743K in Q2 2023.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.